Literature DB >> 25983214

Human Tear Serotonin Levels Correlate with Symptoms and Signs of Dry Eye.

Priyanka Chhadva1, Tinthu Lee1, Constantine D Sarantopoulos2, Abigail S Hackam1, Allison L McClellan3, Elizabeth R Felix4, Roy C Levitt2, Anat Galor5.   

Abstract

PURPOSE: Serotonin, a neurotransmitter known to be involved in nociceptor sensitization, is present in human tears. The purpose of this study was to correlate tear serotonin levels, as a marker of nociceptor sensitization, to facets of dry eye (DE), including symptoms and signs.
DESIGN: Cross-sectional study. PARTICIPANTS: A total of 62 patients with normal eyelid and corneal anatomy were prospectively recruited from a Veterans Administration Ophthalmology Clinic over 11 months.
METHODS: Dry eye symptoms (Ocular Surface Disease Index [OSDI]), signs (tear break-up time [TBUT], corneal staining, and Schirmer's score), and clinical descriptors of neuropathic ocular pain (NOP) (sensitivity to light or sensitivity to wind) were assessed. For tear analysis, each patient's tears were collected after instilling 50 μl of sterile saline to the lower cul-de-sac of each eye and using capillary action microcaps to collect the ocular wash. Tear serotonin levels were measured using enzyme-linked immunosorbent assay. MAIN OUTCOME MEASURES: Correlations between tear serotonin concentrations and DE symptoms and signs.
RESULTS: The mean age of the population was 61±14 years, and 84% (n = 52) of the patients were male. Serotonin concentrations negatively correlated with Schirmer's scores (r = -0.28; P = 0.02) but did not correlate with other DE parameters, such as OSDI scores, sensitivity to light or wind, TBUT, and staining. According to our hypothesis, we divided patients into groups based on both DE symptoms and aqueous tear production; serotonin concentrations were significantly higher in DE group 1 (OSDI ≥6 and Schirmer's <8) compared with both DE group 2 (OSDI ≥6 and Schirmer's ≥8) and controls (OSDI <6 and Schirmer's ≥8). Patients in DE group 2 more frequently reported sensitivity to light (64%) and wind (67%) compared with DE group 1 (40% and 60%, respectively) and controls (8% and 17%, respectively).
CONCLUSIONS: Patients with DE symptoms and aqueous tear deficiency had higher tear serotonin levels compared with those with DE symptoms but normal tear production and those without DE symptoms.
Copyright © 2015 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25983214      PMCID: PMC4516582          DOI: 10.1016/j.ophtha.2015.04.010

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  45 in total

Review 1.  The nerve growth factor 35 years later.

Authors:  R Levi-Montalcini
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

Review 2.  The complex role of serotonin and 5-HT receptors in chronic pain.

Authors:  Laurent Bardin
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

3.  Pain and allodynia/hyperalgesia induced by intramuscular injection of serotonin in patients with fibromyalgia and healthy individuals.

Authors:  M Ernberg; T Lundeberg; S Kopp
Journal:  Pain       Date:  2000-03       Impact factor: 6.961

4.  Impact of dry eye syndrome on vision-related quality of life.

Authors:  Biljana Miljanović; Reza Dana; David A Sullivan; Debra A Schaumberg
Journal:  Am J Ophthalmol       Date:  2007-01-02       Impact factor: 5.258

5.  Nociceptor modulated central sensitization causes mechanical hyperalgesia in acute chemogenic and chronic neuropathic pain.

Authors:  M Koltzenburg; H E Torebjörk; L K Wahren
Journal:  Brain       Date:  1994-06       Impact factor: 13.501

6.  Absence of thermal hyperalgesia in serotonin transporter-deficient mice.

Authors:  Carola Vogel; Rainald Mössner; Manfred Gerlach; Thoralf Heinemann; Dennis L Murphy; Peter Riederer; Klaus-Peter Lesch; Claudia Sommer
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

7.  Performance and repeatability of the NEI-VFQ-25 in patients with dry eye.

Authors:  Kelly K Nichols; G Lynn Mitchell; Karla Zadnik
Journal:  Cornea       Date:  2002-08       Impact factor: 2.651

8.  Behavioural effects of intraplantar injection of inflammatory mediators in the rat.

Authors:  Y Hong; F V Abbott
Journal:  Neuroscience       Date:  1994-12       Impact factor: 3.590

Review 9.  Neuropathic pain: a maladaptive response of the nervous system to damage.

Authors:  Michael Costigan; Joachim Scholz; Clifford J Woolf
Journal:  Annu Rev Neurosci       Date:  2009       Impact factor: 12.449

Review 10.  Dry eye as a mucosal autoimmune disease.

Authors:  Michael E Stern; Chris S Schaumburg; Stephen C Pflugfelder
Journal:  Int Rev Immunol       Date:  2013-02       Impact factor: 5.311

View more
  16 in total

Review 1.  TFOS DEWS II Tear Film Report.

Authors:  Mark D P Willcox; Pablo Argüeso; Georgi A Georgiev; Juha M Holopainen; Gordon W Laurie; Tom J Millar; Eric B Papas; Jannick P Rolland; Tannin A Schmidt; Ulrike Stahl; Tatiana Suarez; Lakshman N Subbaraman; Omür Ö Uçakhan; Lyndon Jones
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

2.  Corneal Dendritic Cell Density Is Associated with Subbasal Nerve Plexus Features, Ocular Surface Disease Index, and Serum Vitamin D in Evaporative Dry Eye Disease.

Authors:  Rohit Shetty; Swaminathan Sethu; Rashmi Deshmukh; Kalyani Deshpande; Arkasubhra Ghosh; Aarti Agrawal; Rushad Shroff
Journal:  Biomed Res Int       Date:  2016-01-24       Impact factor: 3.411

Review 3.  Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine.

Authors:  Suzanne Hagan; Eilidh Martin; Amalia Enríquez-de-Salamanca
Journal:  EPMA J       Date:  2016-07-13       Impact factor: 6.543

Review 4.  Evidence that Dry Eye Represents a Chronic Overlapping Pain Condition.

Authors:  Alexandra E Levitt; Anat Galor; Aneesa R Chowdhury; Elizabeth R Felix; Constantinos D Sarantopoulos; Gerald Y Zhuang; Dennis Patin; William Maixner; Shad B Smith; Eden R Martin; Roy C Levitt
Journal:  Mol Pain       Date:  2017 Jan-Dec       Impact factor: 3.395

5.  The Relationship of Dry Eye Disease with Depression and Anxiety: A Naturalistic Observational Study.

Authors:  Momoko Kitazawa; Chiaki Sakamoto; Michitaka Yoshimura; Motoko Kawashima; Sachiko Inoue; Masaru Mimura; Kazuo Tsubota; Kazuno Negishi; Taishiro Kishimoto
Journal:  Transl Vis Sci Technol       Date:  2018-12-28       Impact factor: 3.283

6.  Biochemical and Functional Changes in the Eye As a Manifestation of Systemic Degeneration of the Nervous System in Parkinsonism.

Authors:  A R Kim; T A Pavlenko; L A Katargina; N B Chesnokova; M V Ugrumov
Journal:  Acta Naturae       Date:  2018 Jul-Sep       Impact factor: 1.845

7.  Evaluation of dry eye disease in newly diagnosed anxiety and depression patients using anterior segment optical coherence tomography.

Authors:  Mahmut Oğuz Ulusoy; Selen Işık-Ulusoy; Sertaç Argun Kıvanç
Journal:  Eye Vis (Lond)       Date:  2019-08-09

Review 8.  Role of tear film biomarkers in the diagnosis and management of dry eye disease.

Authors:  Pak Yui Fong; Kendrick Co Shih; Pun Yuet Lam; Tommy Chung Yan Chan; Vishal Jhanji; Louis Tong
Journal:  Taiwan J Ophthalmol       Date:  2019-09-12

9.  The Relationship Between Ocular Itch, Ocular Pain, and Dry Eye Symptoms (An American Ophthalmological Society Thesis).

Authors:  Anat Galor; Leslie Small; William Feuer; Roy C Levitt; Konstantinos D Sarantopoulos; Gil Yosipovitch
Journal:  Trans Am Ophthalmol Soc       Date:  2018-01-17

10.  Serotonin hormonally regulates lacrimal gland secretory function via the serotonin type 3a receptor.

Authors:  Toshihiro Imada; Shigeru Nakamura; Ryuji Hisamura; Yusuke Izuta; Kai Jin; Masataka Ito; Naoki Kitamura; Kenji F Tanaka; Masaru Mimura; Izumi Shibuya; Kazuo Tsubota
Journal:  Sci Rep       Date:  2017-07-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.